Proposal to list medial devices supplied by ASP New Zealand
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by ASP New Zealand (“ASP”) in Part III of Section H of the Pharmaceutical Schedule from 1 October 2024 in the following category:
Consultation closes at 4pm Friday 6 September 2024 and feedback can be emailed to adyam.markos@pharmac.govt.nz.
What would the effect be?
From 1 October 2024 medical devices supplied by ASP in the category above would be listed under a national agreement for all Health New Zealand | Te Whatu Ora (“Health NZ”) hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply and Health NZ hospitals could continue to purchase other supplier’s brands of sterilisation and decontamination equipment and associated consumables.
The Agreement would supersede any existing Health NZ agreements with ASP for the medical devices included in the Agreement. Any medical device listed in the Agreement and purchased by Health NZ hospitals would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Equipment validation service providers
- Health NZ staff including but not limited to:
- Biomedical engineers (potentially involved in the validation process/outsourced)
- Dental units
- Facilities and support services department
- General ward staff
- Infection prevention and control
- Occupational health and safety department
- Procurement and supply chain department
- Sterile services department
- Theatre staff
- Professional bodies
- New Zealand Nurses Organisation
- Sterile Services Associated NZ
- Suppliers and wholesalers
About these medical devices
Sterilisation and decontamination equipment and associated consumables are medical devices used in surgical and non-surgical procedures primarily to achieve the disinfection and sterilisation of equipment and reusable medical devices. The products vary relating to their purpose, function, application, and clinical indication.
Why we’re proposing this
In August 2021 Pharmac released a Request for Proposals (“RFP”) for Sterilisation and decontamination equipment and associated consumables. The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP and were successful in being progressed to contract negotiation to seek provisional agreements. This is the latest proposal to arise from this process.
Details about our proposal
Pharmac has entered into a provisional agreement with ASP for the supply of sterilisation and decontamination equipment and associated consumables. The proposal would result in listing 59 medical devices on the Pharmaceutical Schedule covering the following brands:
- Access
- Advanced Sterilization Products
- Aptimax
- Cidezyme
- Cidex
- Sterrad
- Timax
- Velocity
To provide feedback
Send us an email: adyam.markos@pharmac.govt.nz by 4pm 6 September 2024.
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.